Marker Therapeutics, Inc.
Hedge Funds Holdings
Last updated:
Marker Therapeutics, Inc.‘s stocks are currently a part of 18 hedge funds’ portfolios, which represents 60.78% of the total amount of its stocks outstanding. This makes up a total of 507.57K shares of Marker Therapeutics, Inc.. Compared to the previous quarter, the number fell by -74.04% or -1.44M shares fewer. As for the holding position changes, 161.11% (29) closed the holdings completely. 17 hedge funds are new holders of Marker Therapeutics, Inc. stock in Q1 2023, it is 94.44% of total holders.
Hedge funds holding Marker Therapeutics (Q3 2018 – Q1 2023)
| Q3 2018 | 1 |
|---|---|
| Q4 2018 | 40 |
| Q1 2019 | 54 |
| Q2 2019 | 68 |
| Q3 2019 | 72 |
| Q4 2019 | 64 |
| Q1 2020 | 63 |
| Q2 2020 | 62 |
| Q3 2020 | 58 |
| Q4 2020 | 59 |
| Q1 2021 | 73 |
| Q2 2021 | 71 |
| Q3 2021 | 60 |
| Q4 2021 | 60 |
| Q1 2022 | 44 |
| Q2 2022 | 42 |
| Q3 2022 | 38 |
| Q4 2022 | 44 |
| Q1 2023 | 18 |
Hedge funds changes in Marker Therapeutics positions (Q3 2018 – Q1 2023)
| Q3 2018 | 1 | 0 | 0 | 0 | 0 |
|---|---|---|---|---|---|
| Q4 2018 | 39 | 1 | 0 | 0 | 0 |
| Q1 2019 | 20 | 13 | 6 | 6 | 9 |
| Q2 2019 | 28 | 15 | 12 | 14 | -1 |
| Q3 2019 | 18 | 24 | 10 | 14 | 6 |
| Q4 2019 | 9 | 21 | 15 | 17 | 2 |
| Q1 2020 | 8 | 16 | 22 | 8 | 9 |
| Q2 2020 | 7 | 21 | 14 | 9 | 11 |
| Q3 2020 | 5 | 14 | 18 | 9 | 12 |
| Q4 2020 | 7 | 18 | 16 | 6 | 12 |
| Q1 2021 | 21 | 21 | 16 | 7 | 8 |
| Q2 2021 | 15 | 17 | 24 | 17 | -2 |
| Q3 2021 | 4 | 12 | 26 | 15 | 3 |
| Q4 2021 | 9 | 9 | 28 | 9 | 5 |
| Q1 2022 | 4 | 8 | 11 | 20 | 1 |
| Q2 2022 | 5 | 3 | 13 | 8 | 13 |
| Q3 2022 | 2 | 7 | 6 | 5 | 18 |
| Q4 2022 | 11 | 9 | 6 | 5 | 13 |
| Q1 2023 | 17 | 0 | 0 | 29 | -28 |
Hedge funds changes in Marker Therapeutics stock options (Q3 2018 – Q1 2023)
| Q3 2018 | 0 | 0 |
|---|---|---|
| Q4 2018 | 190,000 | 12,000 |
| Q1 2019 | 69,000 | 114,000 |
| Q2 2019 | 1,017,000 | 567,000 |
| Q3 2019 | 1,212,000 | 840,000 |
| Q4 2019 | 160,000 | 208,000 |
| Q1 2020 | 191,000 | 33,000 |
| Q2 2020 | 542,000 | 25,000 |
| Q3 2020 | 361,000 | 0 |
| Q4 2020 | 438,000 | 0 |
| Q1 2021 | 1,587,000 | 971,000 |
| Q2 2021 | 2,531,000 | 443,000 |
| Q3 2021 | 749,000 | 247,000 |
| Q4 2021 | 158,000 | 26,000 |
| Q1 2022 | 69,000 | 6,000 |
| Q2 2022 | 50,000 | 0 |
| Q3 2022 | 0 | 0 |
| Q4 2022 | 0 | 0 |
| Q1 2023 | 0 | 0 |